Research agenda 2

June 1, 2007

Aubrey Blumsohn's assessment of the worth of the UK Research Integrity Office (Peep's Diary, May 25) trivialises what is a serious issue. The fact is that the commercialisation of education can only promote research malpractice as universities attempt to cut deals with drugs companies.

The title of this new body creates the illusion that the UK is actually doing something about research fraud but, as The Times Higher pointed out ("Blow the whistle on cheating lab rats", May 11), the body has no regulatory or investigative powers.

If it did have these powers, it would not be receiving funding from the drugs companies.

Pat Brady
Council for Academic Freedom and Academic Standards

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Most Commented

James Fryer illustration (27 July 2017)

It is not Luddism to be cautious about destroying an academic publishing industry that has served us well, says Marilyn Deegan

Jeffrey Beall, associate professor and librarian at the University of Colorado Denver

Creator of controversial predatory journals blacklist says some peers are failing to warn of dangers of disreputable publishers

Hand squeezing stress ball
Working 55 hours per week, the loss of research periods, slashed pensions, increased bureaucracy, tiny budgets and declining standards have finally forced Michael Edwards out
Kayaker and jet skiiers

Nazima Kadir’s social circle reveals a range of alternative careers for would-be scholars, and often with better rewards than academia

hole in ground

‘Drastic action’ required to fix multibillion-pound shortfall in Universities Superannuation Scheme, expert warns